When screening for potential investments, the "Decent Value" approach offers an attractive middle ground. This strategy sits between deep-value and growth investing, seeking out companies that are undervalued relative to their fundamentals but are not broken. The goal is to find stocks that trade at a discount but still demonstrate acceptable levels of profitability, financial health, and growth. For value investors, this method helps avoid the classic "value trap," a stock that looks cheap for the wrong reasons, such as deteriorating business quality. A stock that passes this screen is one where the market may have overlooked solid operations, making it a candidate for revaluation.
Option Care Health Inc (NASDAQ:OPCH) has emerged from this screening process with a notable fundamental rating of 6 out of 10, but more importantly, it scores a strong 8 out of 10 on the Chartmill Valuation rating. This suggests that, according to the available metrics, the stock is priced at a significant discount compared to its industry peers.
Valuation Metrics
The core of the "Decent Value" strategy is a low valuation, and OPCH's numbers are persuasive. The company trades at a Price/Earnings (P/E) ratio of 12.57, which is not only lower than 87.25% of its peers in the Health Care Providers & Services industry but also far below the S&P 500's average of 26.77. This is a clear signal for value investors that the market is pricing the company modestly.
- Price/Earnings (P/E): 12.57 (cheaper than 87.25% of industry peers)
- Price/Forward Earnings: 10.30 (cheaper than 84.31% of industry peers)
- PEG Ratio (NY): Low, indicating the P/E is justified by expected growth.
Furthermore, the enterprise value to EBITDA and price to free cash flow ratios also confirm this cheapness. The low PEG ratio is particularly relevant for value investors; it compensates for the P/E ratio with the company's projected earnings growth, suggesting the current price has not yet priced in future expansion.
Profitability and Health
A cheap stock is only attractive if the company is fundamentally sound. Value investing relies on a "Margin of Safety," which requires that the business itself is healthy and profitable. OPCH scores a 7 on profitability and a 5 on health, which are considered decent for this screening strategy.
Profitability Highlights:
- Return on Assets (ROA): 6.10% (better than 80.39% of peers)
- Return on Equity (ROE): 15.26% (better than 80.39% of peers)
- Return on Invested Capital (ROIC): 9.25% (better than 80.39% of peers)
These metrics show that OPCH is efficient at generating profit from its capital, a key sign of a well-run business. The company also had positive earnings and operating cash flow in each of the last 5 years, a basic but crucial check for value investors.
Health and Solvency:
- Altman-Z Score: 3.55 (indicates low bankruptcy risk; outperforms 71.57% of peers)
- Debt/Equity Ratio: 0.85 (a manageable level of debt)
While the health rating is only a 5, the solvency numbers are solid. The Altman-Z score is comfortably in the safe zone, and the debt is manageable relative to free cash flow. This provides a reasonable buffer, which is essential for a value investment thesis.
Growth Outlook
Value investing does not require hyper-growth, but it does need a catalyst or a path to higher earnings. OPCH demonstrates decent growth, scoring a 6 on the Chartmill Growth rating. This fills the "decent" requirement of the screen.
- Past EPS Growth: Impressive 38.71% over the last year, with a 5-year average of 26.52% per year.
- Past Revenue Growth: 9.30% last year, with a 5-year average of 13.25% per year.
- Future EPS Growth (Expected): 11.96% per year on average.
The combination of a low P/E and a forward EPS growth rate of nearly 12% creates a strong value proposition. The PEG ratio being low suggests that the current valuation is not adequately reflecting this growth potential, a classic scenario for a value investor to investigate further. While revenue growth is expected to slow, the continued earnings growth provides a solid foundation.
Analyst Views and Context
Adding to the valuation case, the broader market trend is positive, which can act as a tailwind for undervalued stocks. The S&P 500 is currently in a positive long-term and short-term trend, suggesting a general appetite for risk. However, OPCH remains cheap relative to the broader market and its own industry.
For a more detailed breakdown of these numbers, you can view the full fundamental analysis report for OPCH here.
Value Trap Considerations
As with all value plays, investors must be wary of the "value trap." OPCH is in the Health Care Providers & Services industry, which can be sensitive to changes in healthcare regulation and reimbursement rates. However, the company's strong profitability ratios (ROE, ROIC) and positive earnings history suggest it is not a distressed asset. The declining gross margin is a point to monitor, but the operating margin has grown nicely, indicating good cost management.
Final Verdict and Further Research
Option Care Health fits the profile of a "Decent Value" stock. It offers a significant valuation discount compared to its industry, supported by strong profitability and a solid, though not perfect, financial health. The growth outlook provides a potential catalyst for the stock price to eventually align with its intrinsic value.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. You should always conduct your own research and consider your financial situation and risk tolerance before making any investment decisions.
If you are interested in finding more stocks that fit this "Decent Value" profile, you can view the full screen results here.
Read full article here »
View the Zacks #1 Rank List
Option Care Health Inc (NASDAQ:OPCH) Screens as a Strong Decent Value Pick with a P/E of 12.57
When screening for potential investments, the "Decent Value" approach offers an attractive middle ground. This strategy sits between deep-value and growth investing, seeking out companies that are undervalued relative to their fundamentals but are not broken. The goal is to find stocks that trade at a discount but still demonstrate acceptable levels of profitability, financial health, and growth. For value investors, this method helps avoid the classic "value trap," a stock that looks cheap for the wrong reasons, such as deteriorating business quality. A stock that passes this screen is one where the market may have overlooked solid operations, making it a candidate for revaluation.
Option Care Health Inc (NASDAQ:OPCH) has emerged from this screening process with a notable fundamental rating of 6 out of 10, but more importantly, it scores a strong 8 out of 10 on the Chartmill Valuation rating. This suggests that, according to the available metrics, the stock is priced at a significant discount compared to its industry peers.
Valuation Metrics
The core of the "Decent Value" strategy is a low valuation, and OPCH's numbers are persuasive. The company trades at a Price/Earnings (P/E) ratio of 12.57, which is not only lower than 87.25% of its peers in the Health Care Providers & Services industry but also far below the S&P 500's average of 26.77. This is a clear signal for value investors that the market is pricing the company modestly.
Furthermore, the enterprise value to EBITDA and price to free cash flow ratios also confirm this cheapness. The low PEG ratio is particularly relevant for value investors; it compensates for the P/E ratio with the company's projected earnings growth, suggesting the current price has not yet priced in future expansion.
Profitability and Health
A cheap stock is only attractive if the company is fundamentally sound. Value investing relies on a "Margin of Safety," which requires that the business itself is healthy and profitable. OPCH scores a 7 on profitability and a 5 on health, which are considered decent for this screening strategy.
Profitability Highlights:
These metrics show that OPCH is efficient at generating profit from its capital, a key sign of a well-run business. The company also had positive earnings and operating cash flow in each of the last 5 years, a basic but crucial check for value investors.
Health and Solvency:
While the health rating is only a 5, the solvency numbers are solid. The Altman-Z score is comfortably in the safe zone, and the debt is manageable relative to free cash flow. This provides a reasonable buffer, which is essential for a value investment thesis.
Growth Outlook
Value investing does not require hyper-growth, but it does need a catalyst or a path to higher earnings. OPCH demonstrates decent growth, scoring a 6 on the Chartmill Growth rating. This fills the "decent" requirement of the screen.
The combination of a low P/E and a forward EPS growth rate of nearly 12% creates a strong value proposition. The PEG ratio being low suggests that the current valuation is not adequately reflecting this growth potential, a classic scenario for a value investor to investigate further. While revenue growth is expected to slow, the continued earnings growth provides a solid foundation.
Analyst Views and Context
Adding to the valuation case, the broader market trend is positive, which can act as a tailwind for undervalued stocks. The S&P 500 is currently in a positive long-term and short-term trend, suggesting a general appetite for risk. However, OPCH remains cheap relative to the broader market and its own industry.
For a more detailed breakdown of these numbers, you can view the full fundamental analysis report for OPCH here.
Value Trap Considerations
As with all value plays, investors must be wary of the "value trap." OPCH is in the Health Care Providers & Services industry, which can be sensitive to changes in healthcare regulation and reimbursement rates. However, the company's strong profitability ratios (ROE, ROIC) and positive earnings history suggest it is not a distressed asset. The declining gross margin is a point to monitor, but the operating margin has grown nicely, indicating good cost management.
Final Verdict and Further Research
Option Care Health fits the profile of a "Decent Value" stock. It offers a significant valuation discount compared to its industry, supported by strong profitability and a solid, though not perfect, financial health. The growth outlook provides a potential catalyst for the stock price to eventually align with its intrinsic value.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. You should always conduct your own research and consider your financial situation and risk tolerance before making any investment decisions.
If you are interested in finding more stocks that fit this "Decent Value" profile, you can view the full screen results here.
Read full article here »